Simpson Carpenter Launches New Healthcare Division

Simpson Carpenter today announces that the agency is moving into healthcare and pharmaceutical research with the launch of a new division.

Heading up the new healthcare division will be career pharmaceutical market researcher Anna Sawka who joins from Aequus Research.

As Head of Healthcare Research at the agency, Anna will lead a team of specialist researchers and be responsible for spearheading Simpson Carpenter’s entry into the market.

Further appointments are planned for early 2011.
Previously Director at Aequus, Anna brings over 12 years’ worth of experience conducting pharmaceutical market research to Simpson Carpenter. Having worked for a number of pharmaceutical and biotech companies, Anna offers a huge breadth of expertise in conducting research throughout the entire product lifecycle.

In addition to assisting companies with tactical business issues such as communication platform development and testing, Anna has extensive experience in strategic market assessment projects for early development and pipeline products and is skilled at advising companies on the likely return on investment for new initiatives.

With the launch of a healthcare division, Simpson Carpenter will bring a more consumer centric focus to traditional pharmaceutical research.

Commenting on her appointment, Anna said,
“I am delighted to be joining the Simpson Carpenter team and to be able to draw on their consumer expertise. There has been a significant shift within pharmaceutical research recently as we see patients becoming more active participants in virtually every aspect of healthcare. There is a real need, therefore, to adapt our approaches to research and understand patients as consumers rather than merely focusing on researching medical professionals.

I’ve noticed a real interest amongst my clients to engage patients more effectively and I think there is a huge opportunity for an agency such as Simpson Carpenter with a superb track record in understanding how consumers think and behave to breathe new life into pharmaceutical research. I am really looking forward to establishing Simpson Carpenter as a major player within pharmaceutical research and I am confident that we have a very compelling offering to bring to our clients.”

The team will offer a full range of qualitative and quantitative methodologies together with capabilities for advanced analysis including conjoint and segmentation models.

In addition to providing a hotline to patients, Simpson Carpenter will draw on Anna’s extensive experience of working with opinion leaders,physicians,nurses, and hard-to-reach groups.

Tom Simpson, Managing Director said,
“We are delighted to welcome Anna on board and to be debuting in a new sector in 2011. Having the very best sector specialists on board is absolutely central to our strategy and a key point of difference for our clients. Anna’s experience within the healthcare sector is extensive and she has an extremely strong track record of building strong client relationships. The combination of Simpson Carpenter’s deep understanding of consumer behaviour and attitudes with the expertise of a highly experienced team of pharmaceutical market researchers should be an exciting proposition for forward thinking healthcare companies.”